Radnor Capital Management, LLC Eli Lilly & CO Transaction History

Radnor Capital Management, LLC

$586 Million
Q1 2024

A detailed history of Radnor Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Radnor Capital Management, LLC holds 10,536 shares of LLY stock, worth $9.55 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

10,536

Previous 10,761 2.09%

Holding current value

$9.55 Million

Previous $6.27 Million 30.67%

% of portfolio

1.4%

Previous 1.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $133,245 - $178,263	-225 Reduced 2.09%	10,536 $8.2 Million
Q4 2023 Jan 11, 2024	SELL	$525.19 - $619.13 $525 - $619	-1 Reduced 0.01%	10,761 $6.27 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $4.68 Million - $6.45 Million	10,762 New	10,762 $5.78 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $633,374 - $743,867	2,039 Added 43.93%	6,681 $2.29 Million
Q4 2022 Jan 09, 2023	SELL	$321.55 - $374.67 $1,929 - $2,248	-6 Reduced 0.13%	4,642 $1.67 Million

Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $110,290 - $125,687	-372 Reduced 7.41%	4,648 $1.5 Million
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $80,831 - $94,908	-290 Reduced 5.46%	5,020 $1.63 Million
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $82,610 - $102,664	352 Added 7.1%	5,310 $1.52 Million
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $1.11 Million - $1.38 Million	4,958 New	4,958 $1.37 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $1.2 Million - $1.48 Million	-5,420 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $88,469 - $114,434	-490 Reduced 8.29%	5,420 $1.24 Million
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $19,569 - $25,894	150 Added 2.6%	5,910 $998,000
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $43,866 - $50,739	-300 Reduced 4.95%	5,760 $853,000
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 3.19%	6,060 $990,000
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $53,572 - $66,307	-450 Reduced 6.71%	6,260 $868,000
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $55,395 - $64,660	-500 Reduced 6.93%	6,710 $743,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $211,489 - $248,938	-1,900 Reduced 20.86%	7,210 $936,000
Q4 2018 Jan 16, 2019	SELL	$105.9 - $118.64 $32,829 - $36,778	-310 Reduced 3.29%	9,110 $1.05 Million
Q3 2018 Oct 04, 2018	SELL	$85.86 - $107.31 $34,773 - $43,460	-405 Reduced 4.12%	9,420 $1.01 Million
Q2 2018 Jul 10, 2018	SELL	$75.7 - $86.88 $11,355 - $13,032	-150 Reduced 1.5%	9,825 $838,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $15,568 - $16,699	-190 Reduced 1.87%	9,975 $842,000
Q2 2017 Aug 09, 2017	BUY	N/A	10,165	10,165 $837,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Eli Lilly & CO Transaction History